Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rozek, L. S.
Right arrow Articles by Gruber, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rozek, L. S.
Right arrow Articles by Gruber, S. B.
[Cancer Research 65, 5488-5492, July 1, 2005]
© 2005 American Association for Cancer Research


Priority Reports

CDX2 Polymorphisms, RNA Expression, and Risk of Colorectal Cancer

Laura S. Rozek1,5, Steven M. Lipkin7, Eric R. Fearon1,2,3, Samir Hanash4, Thomas J. Giordano3, Joel K. Greenson3, Rork Kuick4, David E. Misek4, Jeremy M.G. Taylor6, Julie A. Douglas2, Gad Rennert8,9 and Stephen B. Gruber1,2,5

Departments of 1 Internal Medicine, 2 Human Genetics, 3 Pathology, and 4 Pediatrics, University of Michigan Medical School; Departments of 5 Epidemiology and 6 Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan; 7 Division of Hematology-Oncology, Department of Medicine, University of California, Irvine, California; 8 Department of Community Medicine and Epidemiology, Carmel Medical Center and Technion Faculty of Medicine; and 9 CHS National Cancer Control Center, Haifa, Israel

Requests for reprints: Stephen B. Gruber, Division of Molecular Medicine and Genetics, University of Michigan, 4301 MSRB III, Box 0638, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0638. Phone: 734-615-9712; Fax: 734-763-7672; E-mail: sgruber{at}umich.edu.

In adult mammals, CDX2 acts as a transcription factor and is expressed in intestinal epithelial cells. Down-regulation of CDX2 is frequently observed in colorectal cancer, suggesting its loss may cause dedifferentiation of gastrointestinal epithelial cells. However, it is not clear whether inherited variants of CDX2 are associated with risk of colorectal cancer. Using epidemiologic data and tumors from a population-based case-control study in Israel, we identified novel single nucleotide polymorphisms (SNPs) by resequencing 35 cases, compared genotype and haplotype frequencies in 455 matched pairs, and characterized the tumor characteristics of all 455 cases by microsatellite instability analysis, in addition to a partially overlapping set of 201 frozen tumors with expression profiling data (82/201) from the same study. Nine polymorphisms were identified in the 35 cases, and none of the SNPs or haplotypes were associated with risk of colorectal cancer in the 455 matched pairs. These variants were not associated with CDX2 expression in the 83 subjects with expression data. We evaluated subject and tumor characteristics in the 201 subjects with CDX2 tumor expression data. Reduced CDX2 expression was associated with tumor location (right sided), poor differentiation, high microsatellite instability status, and a positive first-degree family history. We conclude that it is unlikely that common CDX2 variants account for a measurable fraction of susceptibility to colorectal cancer in this population. However, CDX2 expression levels were strongly associated with microsatellite instability and tumor location in the gastrointestinal tract, consistent with a possible role in the specification of gastrointestinal epithelial cell fate in humans.




This article has been cited by other articles:


Home page
Ann OncolHome page
F. Perrone, A. Lampis, M. Orsenigo, M. Di Bartolomeo, A. Gevorgyan, M. Losa, M. Frattini, C. Riva, S. Andreola, E. Bajetta, et al.
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
Ann. Onc., July 31, 2008; (2008) mdn541v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Cicek, X. Liu, F. R. Schumacher, G. Casey, and J. S. Witte
Vitamin D Receptor Genotypes/Haplotypes and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2549 - 2552.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J O'Loughlin, E Dugas, K Maximova, and N Kishchuk
Reporting of ethnicity in research on chronic disease: update
Postgrad. Med. J., November 1, 2006; 82(973): 737 - 742.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. C. Chao and S. M. Lipkin
Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis
Nucleic Acids Res., February 6, 2006; 34(3): 840 - 852.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.